A new inter partes review, IPR2026-00400, was filed on June 22, 2026, at the Patent Trial and Appeal Board against Thorne Research, Inc. The proceeding is one to watch for companies operating at the intersection of dietary supplements, formulations, and health-focused consumer products, where patent value often turns on how broadly claims are drafted and how well they withstand validity attacks based on published prior art.

At this stage, the publicly available docket information identifies Thorne Research, Inc. as the patent owner, but practitioners should review the petition and related filings to confirm the specific challenged patent, the real parties in interest, and the exact claims at issue as the record develops.